scispace - formally typeset
Open Access

ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof, +3 more
- Vol. 70, Iss: 1, pp 1-84
About
The article was published on 2017-01-01 and is currently open access. It has received 3603 citations till now. The article focuses on the topics: Management of atrial fibrillation.

read more

Citations
More filters
Journal ArticleDOI

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

TL;DR: Authors/Task Force Members: Piotr Ponikowski* (Chairperson) (Poland), Adriaan A. Voors* (Co-Chair person) (The Netherlands), Stefan D. Anker (Germany), Héctor Bueno (Spain), John G. F. Cleland (UK), Andrew J. S. Coats (UK)
Journal ArticleDOI

2018 ESC/EACTS Guidelines on myocardial revascularization.

TL;DR: Authors/Task Force Members: Franz-Josef Neumann* (ESC Chairperson) (Germany), Miguel Sousa-Uva* (EACTS Chair person) (Portugal), Anders Ahlsson (Sweden), Fernando Alfonso (Spain), Adrian P. Banning (UK), Umberto Benedetto (UK).
Journal ArticleDOI

2017 HRS / EHRA / ECAS / APHRS / SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

Hugh Calkins, +60 more
- 01 Oct 2017 - 
TL;DR: This 2017 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AF and to report the findings of a writing group, convened by these five international societies.
References
More filters
Journal ArticleDOI

Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs.

TL;DR: Reversal of CHF is followed by normalized atrial function and decreased duration of AF; however, fibrosis and conduction abnormalities are not reversible, and a substrate that can support prolonged AF remains.
Journal ArticleDOI

Atrial fibrillation and stroke: new ideas, persisting dilemmas.

Jonathan L. Halperin, +1 more
- 01 Aug 1988 - 
TL;DR: The risk of systemic embolism associated with atrial fibrillation in patients with rheumatic mitral valve disease and nonrheumatic AF is a marker of increased risk for ischemic stroke and major unanswered questions remain in three related areas.
Journal ArticleDOI

Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis

TL;DR: Current knowledge gaps and areas that warrant future research are highlighted, which might advance understanding of variation in the risk factors and complications of AF, and ultimately aid more-tailored management of the arrhythmia.
Journal ArticleDOI

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

Paulus Kirchhof, +55 more
- 01 Jan 2012 - 
TL;DR: The proceedings of the 3rd Atrial Fibrillation NETwork (AFNET)/European Heart Rhythm Association (EHRA) consensus conference that convened over 60 scientists and representatives from industry to jointly discuss emerging therapeutic and diagnostic improvements to achieve better management of AF patients are described.
Journal ArticleDOI

The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study

TL;DR: The risk of atrial fibrillation was closely associated with thyroid activity, with a low risk in overt hypothyroidism, high risk in hyperthyroidism and a TSH level dependent association with risk ofAtrial fafibrillation across the spectrum of subclinical thyroid disease.
Related Papers (5)